Supernus Pharmaceuticals
SUPN
#4425
Rank
NZ$3.15 B
Marketcap
$56.48
Share price
-0.40%
Change (1 day)
-1.06%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): NZ$0.16 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.66 Billion. , an increase over its 2023 earnings that were of NZ$9.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.17 B1787.92%
2023 NZ$9.06 M-92.36%
2022 NZ$0.11 B-29.8%
2021 NZ$0.16 B-49.79%
2020 NZ$0.33 B12.99%
2019 NZ$0.29 B7.58%
2018 NZ$0.27 B54.9%
2017 NZ$0.17 B84.25%
2016 NZ$97.01 M202.27%
2015 NZ$32.09 M-462.04%
2014 -NZ$8.87 Million-94%
2013 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.38 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.76 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.18 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.66 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.26 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.51 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA